| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 17 | +76.47% | -2.47% | -0.52% | -1.96% | -1.18% | — |
| 14d | 17 | +52.94% | -1.71% | +0.04% | -1.74% | -1.79% | — |
| 30d | 17 | +52.94% | +0.08% | +0.77% | -0.69% | -2.47% | — |
| 60d | 17 | +58.82% | +0.31% | +3.51% | -3.20% | -8.37% | — |
| 90d | 17 | +70.59% | -8.92% | +3.85% | -12.94% | -25.16% | — |
| 180d | 17(1 pending) | +87.50% | +0.72% | +4.78% | -3.99% | -29.13% | — |
| 1y | 17(3 pending) | +71.43% | +23.22% | +6.30% | +16.93% | -32.51% | — |
| 2y | 17(6 pending) | +100.00% | -52.21% | +11.46% | -63.68% | -65.03% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CRNX CRINETICS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 9,730 | — | — | 9,730 | Jun 18, 2026 | Jun 22, 2026 ↗ | View → |
| CRNX CRINETICS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 5,925 | — | — | 22,225 | Jun 18, 2026 | Jun 22, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 143,985 | — | — | 143,985 | Mar 5, 2026 | Mar 9, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 95,990 | — | — | 265,285 | Mar 5, 2026 | Mar 9, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 6,461 | $14.58 | $94.2K | 169,295 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 6,580 | $14.35 | $94.4K | 175,756 | Dec 1, 2025 | Dec 3, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 12,039 | $14.58 | $175.5K | 182,336 | Sep 30, 2025 | Oct 2, 2025 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 7,037 | — | — | 7,037 | Jun 24, 2025 | Jun 26, 2025 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 4,712 | — | — | 4,712 | Jun 24, 2025 | Jun 26, 2025 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | SALE | 4,000 | — | — | 0 | Jun 18, 2025 | Jun 23, 2025 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASE | 4,000 | — | — | 7,000 | Jun 18, 2025 | Jun 23, 2025 ↗ | View → |
| CRNX CRINETICS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 6,900 | — | — | 16,300 | Jun 11, 2025 | Jun 13, 2025 ↗ | View → |
| CRNX CRINETICS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 10,350 | — | — | 10,350 | Jun 11, 2025 | Jun 13, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 12,425 | $3.47 | $43.1K | 194,375 | Mar 31, 2025 | Apr 2, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 102,630 | — | — | 102,630 | Mar 6, 2025 | Mar 10, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 68,420 | — | — | 206,800 | Mar 6, 2025 | Mar 10, 2025 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 5,421 | $5.54 | $30.0K | 138,380 | Dec 2, 2024 | Dec 4, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 11,442 | $3.20 | $36.6K | 143,801 | Sep 30, 2024 | Oct 2, 2024 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASE | 3,000 | — | — | 3,000 | Jun 21, 2024 | Jun 25, 2024 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | SALE | 3,000 | — | — | 0 | Jun 21, 2024 | Jun 25, 2024 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 4,000 | — | — | 4,000 | Jun 18, 2024 | Jun 20, 2024 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 14,000 | — | — | 14,000 | Jun 18, 2024 | Jun 20, 2024 ↗ | View → |
| CRNX CRINETICS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 12,500 | — | — | 12,500 | Jun 7, 2024 | Jun 11, 2024 ↗ | View → |
| CRNX CRINETICS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 3,400 | — | — | 9,400 | Jun 7, 2024 | Jun 11, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Apr 16, 2024 | Apr 18, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 96,910 | — | — | 155,243 | Apr 16, 2024 | Apr 18, 2024 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 58,333 | — | — | 58,333 | Nov 27, 2023 | Nov 29, 2023 ↗ | View → |
| AMLX AMYLYX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 162,500 | — | — | 162,500 | Nov 27, 2023 | Nov 29, 2023 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 3,000 | — | — | 3,000 | Jun 21, 2023 | Jun 23, 2023 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 14,000 | — | — | 14,000 | Jun 21, 2023 | Jun 23, 2023 ↗ | View → |
| CRNX CRINETICS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 17,500 | — | — | 17,500 | Jun 16, 2023 | Jun 21, 2023 ↗ | View → |
| CRNX CRINETICS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 6,000 | — | — | 6,000 | Jun 16, 2023 | Jun 21, 2023 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 2,663 | — | — | 50,601 | Mar 1, 2023 | Mar 3, 2023 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 3,881 | $45.25 | $175.6K | 46,720 | Mar 1, 2023 | Mar 3, 2023 ↗ | View → |
| CRNX CRINETICS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 17,500 | — | — | 17,500 | Jun 17, 2022 | Jun 21, 2022 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | Jun 8, 2022 | Jun 10, 2022 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 14,000 | — | — | 47,938 | Mar 1, 2022 | Mar 3, 2022 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 24,900 | — | — | 24,900 | Mar 1, 2022 | Mar 3, 2022 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 2,821 | $66.62 | $187.9K | 33,938 | Mar 1, 2022 | Mar 3, 2022 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 1,657 | $66.30 | $109.9K | 36,759 | Jan 30, 2022 | Feb 1, 2022 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 359 | $81.14 | $29.1K | 38,416 | Oct 14, 2021 | Oct 18, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 2,500 | — | — | 53,000 | Sep 2, 2021 | Sep 2, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 2,500 | $100.18 | $250.4K | 38,775 | Sep 2, 2021 | Sep 2, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASE EVP and Chief Medical Officer | 2,500 | $55.00 | $137.5K | 41,275 | Sep 2, 2021 | Sep 2, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASE EVP and Chief Medical Officer | 2,500 | $55.00 | $137.5K | 41,275 | Sep 1, 2021 | Sep 2, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 2,500 | $100.03 | $250.1K | 38,775 | Sep 1, 2021 | Sep 2, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 2,500 | — | — | 55,500 | Sep 1, 2021 | Sep 2, 2021 ↗ | View → |
| CRNX CRINETICS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 17,500 | — | — | 17,500 | Jun 22, 2021 | Jun 23, 2021 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 15,000 | Jun 9, 2021 | Jun 11, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 364 | $113.67 | $41.4K | 38,775 | May 6, 2021 | May 10, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 5,000 | $109.09 | $545.5K | 39,139 | Apr 15, 2021 | Apr 19, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 5,000 | — | — | 58,000 | Apr 15, 2021 | Apr 19, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASE EVP and Chief Medical Officer | 5,000 | $55.00 | $275.0K | 44,139 | Apr 15, 2021 | Apr 19, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 4,636 | — | — | 43,682 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 5,500 | — | — | 39,046 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 11,000 | — | — | 11,000 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 4,543 | $138.18 | $627.8K | 39,139 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 2,243 | $140.36 | $314.8K | 33,546 | Jan 30, 2021 | Feb 2, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASE EVP and Chief Medical Officer | 25,000 | $55.00 | $1.38M | 60,789 | Jan 15, 2021 | Jan 19, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 25,000 | $139.18 | $3.48M | 35,789 | Jan 15, 2021 | Jan 19, 2021 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 25,000 | — | — | 63,000 | Jan 15, 2021 | Jan 19, 2021 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 37,000 | — | — | 37,000 | Dec 9, 2020 | Dec 11, 2020 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 262 | $88.00 | $23.1K | 35,789 | Oct 14, 2020 | Oct 16, 2020 ↗ | View → |
| CRNX CRINETICS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Sep 1, 2020 | Sep 3, 2020 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 249 | $66.26 | $16.5K | 36,051 | May 6, 2020 | May 8, 2020 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 21,000 | — | — | 21,000 | Mar 1, 2020 | Mar 3, 2020 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 1,249 | $56.08 | $70.0K | 36,300 | Mar 1, 2020 | Mar 3, 2020 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 5,634 | — | — | 37,549 | Mar 1, 2020 | Mar 3, 2020 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | PURCHASEGRANT Stock grant | 7,300 | — | — | 31,915 | Mar 1, 2020 | Mar 3, 2020 ↗ | View → |
| RARE ULTRAGENYX PHARMACEUTICAL INC. | SALE EVP and Chief Medical Officer | 1,624 | $53.23 | $86.4K | 24,615 | Jan 30, 2020 | Jan 31, 2020 ↗ | View → |